Russell L. Skibsted's most recent trade in Processa Pharmaceuticals Inc was a trade of 1,775,044 Restricted Stock Units done . Disclosure was reported to the exchange on July 24, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Processa Pharmaceuticals Inc | Russell L. Skibsted | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2025 | 1,775,044 | 1,803,044 | - | - | Restricted Stock Units | |
Processa Pharmaceuticals Inc | Russell L. Skibsted | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2024 | 28,000 | 28,000 | - | - | Restricted Stock Units | |
Alimera Sciences Inc. | Russell L. Skibsted | Chief Financial Officer & SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2023 | 58,000 | 75,500 (1%) | 1% | 0 | Common Stock | |
Alimera Sciences Inc. | Russell L. Skibsted | Chief Financial Officer & SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 52,500 | 52,500 | - | - | Employee Stock Option (Right to Buy) | |
Alimera Sciences Inc. | Russell L. Skibsted | Chief Financial Officer & SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 17,500 | 17,500 (0%) | 0% | 0 | Common Stock | |
Rockwell Medical Inc | Russell L. Skibsted | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2022 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
Rockwell Medical Inc | Russell L. Skibsted | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 600,000 | 600,000 | - | - | Stock Option (Right to Buy) | |
Rockwell Medical Inc | Russell L. Skibsted | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |